Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 3 Interventional

Safety and Efficacy Study of Cenobamate in Pediatric Subjects 2-17 Years of Age With Partial-onset (Focal) Seizures

ClinicalTrials.gov ID: NCT05067634

Public ClinicalTrials.gov record NCT05067634. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 10, 2026, 10:49 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Open-Label Safety and Efficacy Study of Cenobamate in Pediatric Subjects 2-17 Years of Age With Partial-onset (Focal) Seizures

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Primary objective: To evaluate the safety and tolerability of cenobamate in pediatric subjects 2-17 years of age with partial-onset (focal) seizures

Study identification

NCT ID
NCT05067634
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
SK Life Science, Inc.
Industry
Enrollment
140 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
2 Years to 18 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 9, 2022
Primary completion
Oct 31, 2026
Completion
Oct 31, 2026
Last update posted
Sep 8, 2026

2022 – 2026

United States locations

U.S. sites
14
U.S. states
12
U.S. cities
14
Facility City State ZIP Site status
Phoenix Children's Hospital Phoenix Arizona 85016
Lucile Packard Children's Hospital Stanford Palo Alto California 94304
Connecticut Children's Medical Center Hartford Connecticut 06106
Clinical Integrative Research Center of Atlanta Sandy Springs Georgia 30328
Mid-Atlantic Epilepsy and Sleep Center Bethesda Maryland 20817
Mayo Clinic - Rochester Rochester Minnesota 55905
Northeast Regional Epilepsy Group Hackensack New Jersey 07601
Northeast Regional Epilepsy Group - Morristown Morristown New Jersey 07960
Boston Children's Health Physicians - Neurology at Hawthorne Hawthorne New York 10532
Duke University Hospital Durham North Carolina 27710
Cincinnati Children's Hospital Cincinnati Ohio 45229
Cleveland Clinic Main Campus Cleveland Ohio 44195
Le Bonheur Children's Hospital Memphis Tennessee 38103
Child Neurology Consultants of Austin Austin Texas 78731

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 21 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05067634, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 8, 2026 · Synced Sep 10, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05067634 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →